Zoetis
ZTS
$2.50 (1.51%)
1D
1W
3M
1Y
5Y
ALL
Zoetis Inc. is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products, biodevices, genetic tests and precision livestock farming technology. The Company has a business, commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, swine, poultry, fish and sheep (collectively, livestock); and within product categories such as vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
PRNewsWire • 1 day ago • ZTS
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zoetis Inc. - ZTSZacks Investment Research • 2 days ago • ZTS
Is Trending Stock Zoetis Inc. (ZTS) a Buy Now?Seeking Alpha • 4 days ago • ZTS
Zoetis: Long-Term Buy Despite Safety ConcernsThe Motley Fool • 5 days ago • ZTS
Why Zoetis Stock Popped by Almost 6% on ThursdayCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.